$ALTS
ALT5 Sigma Corp

2020 Q3 Form 10-Q Financial Statement

#000156459020052676 Filed on November 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q4 2019 Q3
Revenue $12.27M $11.41M $9.790M
YoY Change 25.29% 23.48% -4.65%
Cost Of Revenue $8.549M $9.210M $7.226M
YoY Change 18.31% 50.0% 5.12%
Gross Profit $3.717M $2.210M $2.564M
YoY Change 44.97% -28.71% -24.43%
Gross Profit Margin 30.3% 19.37% 26.19%
Selling, General & Admin $4.540M $6.750M $5.185M
YoY Change -12.44% 54.82% 2.39%
% of Gross Profit 122.14% 305.43% 202.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.060M $1.030M $1.076M
YoY Change -1.49% 1.98% 6.64%
% of Gross Profit 28.52% 46.61% 41.97%
Operating Expenses $4.540M $6.750M $5.185M
YoY Change -12.44% 54.82% 2.39%
Operating Profit -$823.0K -$4.540M -$2.621M
YoY Change -68.6% 260.32% 56.85%
Interest Expense -$90.00K -$1.400M -$80.00K
YoY Change 12.5% -14100.0% 60.0%
% of Operating Profit
Other Income/Expense, Net -$86.00K $260.0K -$69.00K
YoY Change 24.64% 188.89% -133.5%
Pretax Income -$909.0K -$7.980M -$2.690M
YoY Change -66.21% 582.05% 83.62%
Income Tax -$99.00K -$1.370M -$732.0K
% Of Pretax Income
Net Earnings -$810.0K -$6.610M -$1.958M
YoY Change -58.63% 340.67% 55.4%
Net Earnings / Revenue -6.6% -57.93% -20.0%
Basic Earnings Per Share -$0.43 -$1.14
Diluted Earnings Per Share -$0.43 -$3.355M -$1.14
COMMON SHARES
Basic Shares Outstanding 1.871M 1.722M
Diluted Shares Outstanding 1.871M 1.722M

Balance Sheet

Concept 2020 Q3 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $640.0K $480.0K $640.0K
YoY Change 0.0% -60.0% -11.11%
Cash & Equivalents $638.0K $481.0K $638.0K
Short-Term Investments
Other Short-Term Assets $930.0K $360.0K $850.0K
YoY Change 9.41% -65.38% -10.53%
Inventory $1.070M $1.348M $1.730M
Prepaid Expenses
Receivables $6.102M $7.226M $6.839M
Other Receivables $180.0K $189.0K $165.0K
Total Short-Term Assets $7.990M $8.839M $9.240M
YoY Change -13.53% -1.1% -6.57%
LONG-TERM ASSETS
Property, Plant & Equipment $2.710M $324.0K $802.0K
YoY Change 237.91% 53.55% 48.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $67.00K $77.00K $91.00K
YoY Change -26.37% -23.0% -86.42%
Total Long-Term Assets $17.89M $20.20M $24.40M
YoY Change -26.69% -22.63% -9.45%
TOTAL ASSETS
Total Short-Term Assets $7.990M $8.839M $9.240M
Total Long-Term Assets $17.89M $20.20M $24.40M
Total Assets $25.88M $29.03M $33.64M
YoY Change -23.07% -17.14% -8.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.250M $4.365M $3.726M
YoY Change -39.61% 37.74% -1.69%
Accrued Expenses $5.727M $3.938M $1.312M
YoY Change 336.51% 252.24% -77.65%
Deferred Revenue $853.0K $515.0K
YoY Change
Short-Term Debt $3.327M $280.0K $791.0K
YoY Change 320.61% -58.52%
Long-Term Debt Due $3.330M $280.0K $790.0K
YoY Change 321.52% -58.82% 68.09%
Total Short-Term Liabilities $19.25M $17.57M $11.56M
YoY Change 66.52% 81.46% 14.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $2.500M
YoY Change -100.0%
Other Long-Term Liabilities $1.350M $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $1.350M $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.25M $17.57M $11.56M
Total Long-Term Liabilities $1.350M $0.00 $0.00
Total Liabilities $20.60M $18.69M $16.94M
YoY Change 21.63% 39.2% 23.28%
SHAREHOLDERS EQUITY
Retained Earnings -$33.95M -$28.42M -$21.88M
YoY Change 55.22% 72.05%
Common Stock $39.82M $39.29M $39.11M
YoY Change 1.81% 1.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.274M $10.34M $16.70M
YoY Change
Total Liabilities & Shareholders Equity $25.88M $29.03M $33.64M
YoY Change -23.08% -17.14% -8.68%

Cashflow Statement

Concept 2020 Q3 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income -$810.0K -$6.610M -$1.958M
YoY Change -58.63% 340.67% 55.4%
Depreciation, Depletion And Amortization $1.060M $1.030M $1.076M
YoY Change -1.49% 1.98% 6.64%
Cash From Operating Activities $580.0K $130.0K -$2.520M
YoY Change -123.02% -84.34% -427.27%
INVESTING ACTIVITIES
Capital Expenditures -$150.0K -$60.00K -$210.0K
YoY Change -28.57% -70.0% 950.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$30.00K -$240.0K
YoY Change -100.0% -150.0% -2500.0%
Cash From Investing Activities -$150.0K -$100.0K -$440.0K
YoY Change -65.91% -28.57% 4300.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -640.0K -160.0K 2.250M
YoY Change -128.44% -36.0% -611.36%
NET CHANGE
Cash From Operating Activities 580.0K 130.0K -2.520M
Cash From Investing Activities -150.0K -100.0K -440.0K
Cash From Financing Activities -640.0K -160.0K 2.250M
Net Change In Cash -210.0K -130.0K -710.0K
YoY Change -70.42% -129.55% -321.88%
FREE CASH FLOW
Cash From Operating Activities $580.0K $130.0K -$2.520M
Capital Expenditures -$150.0K -$60.00K -$210.0K
Free Cash Flow $730.0K $190.0K -$2.310M
YoY Change -131.6% -81.55% -392.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
270000
CY2020Q3 us-gaap Liabilities
Liabilities
20603000
CY2019Q4 us-gaap Liabilities
Liabilities
18693000
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
2000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
39814000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
39291000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-588000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-533000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33954000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5274000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
10341000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25877000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29034000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
259729
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
259729
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
259729
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
259729
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1829982
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1919048
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1829982
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1919048
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12266000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9790000
CY2019Q3 us-gaap Gross Profit
GrossProfit
2564000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-823000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2621000
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-88000
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-75000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-86000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-69000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-909000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2690000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-99000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-732000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1860270
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1703559
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1860270
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1703559
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-55000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-55000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5590000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5354000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-810000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1958000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.98
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.14
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.14
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1871321
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1721547
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1871321
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1721547
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-27000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-27000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-837000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1972000
us-gaap Profit Loss
ProfitLoss
-5535000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3104000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3046000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
27000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
111000
us-gaap Share Based Compensation
ShareBasedCompensation
523000
us-gaap Share Based Compensation
ShareBasedCompensation
447000
jan Non Cash Lease Expense
NonCashLeaseExpense
137000
jan Non Cash Lease Expense
NonCashLeaseExpense
33000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
48000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-148000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
270000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1823000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
40000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1561000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
254000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
47000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-71000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-277000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
919000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-77000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
708000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1042000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3643000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
436000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
281000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-881000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-293000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
445000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
3469000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2616000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-557000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
638000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
638000
us-gaap Interest Paid Net
InterestPaidNet
71000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
44000
jan Right To Use Asset Operating Leases Capitalized
RightToUseAssetOperatingLeasesCapitalized
1037000
jan Right To Use Asset Operating Leases Capitalized
RightToUseAssetOperatingLeasesCapitalized
2272000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
6099000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
21611000
jan Payment Of Related Party Note
PaymentOfRelatedPartyNote
-2500000
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
422000
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
355000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1547000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-55000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
157000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
481000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1195000
us-gaap Interest Paid Net
InterestPaidNet
126000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
76000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-810000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
18229000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
447000
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-1958000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
16704000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
523000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
471000
jan Payment Of Related Party Note
PaymentOfRelatedPartyNote
1500000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumption that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant estimates made in connection with the accompanying consolidated financial statements include the estimated reserve for doubtful current and long-term trade and other receivables, the estimated reserve for excess and obsolete inventory, estimated fair value and forfeiture rates for stock-based compensation, fair values in connection with the analysis of other intangibles and long-lived assets for impairment, valuation allowance against deferred tax assets and estimated useful lives for intangible assets and property and equipment.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains cash balances at several banks in several states including, Minnesota, California, and Nevada. Accounts are insured by the Federal Deposit Insurance Corporation up to $250 per institution as of September&#160;26, 2020. At times, balances may exceed federally insured limits.</p>
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
29000
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2019 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2020Q2 us-gaap Deferred Costs
DeferredCosts
0
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
jan Increase Decrease In Working Capital
IncreaseDecreaseInWorkingCapital
-11264000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
29000
CY2019Q4 us-gaap Deferred Costs
DeferredCosts
0
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11562000
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8891000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
23239000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21397000
CY2020Q3 us-gaap Advertising Expense
AdvertisingExpense
162000
CY2019Q3 us-gaap Advertising Expense
AdvertisingExpense
168000
us-gaap Advertising Expense
AdvertisingExpense
284000
us-gaap Advertising Expense
AdvertisingExpense
623000
jan Operating Lease Lease Expiration Year
OperatingLeaseLeaseExpirationYear
2024
CY2020Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P6M
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P31M
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6102000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7226000
CY2020Q3 jan Factored Accounts Receivable Current
FactoredAccountsReceivableCurrent
-1544000
CY2019Q4 jan Factored Accounts Receivable Current
FactoredAccountsReceivableCurrent
-2165000
CY2020Q3 us-gaap Accounts Receivable From Securitization
AccountsReceivableFromSecuritization
281000
CY2019Q4 us-gaap Accounts Receivable From Securitization
AccountsReceivableFromSecuritization
415000
CY2019Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
913000
CY2020Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
180000
CY2019Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
189000
CY2020Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4728000
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5928000
CY2020Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1403000
CY2019Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1327000
CY2020Q3 us-gaap Retail Related Inventory
RetailRelatedInventory
871000
CY2019Q4 us-gaap Retail Related Inventory
RetailRelatedInventory
1148000
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
200000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
200000
CY2020Q3 us-gaap Prepaid Insurance
PrepaidInsurance
478000
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
282000
CY2020Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
453000
us-gaap Operating Lease Payments
OperatingLeasePayments
965000
us-gaap Operating Lease Payments
OperatingLeasePayments
913000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1271000
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-234000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
74000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2515000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2503000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2247000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2179000
CY2020Q3 us-gaap Depreciation
Depreciation
27000
CY2019Q3 us-gaap Depreciation
Depreciation
87000
us-gaap Depreciation
Depreciation
68000
us-gaap Depreciation
Depreciation
250000
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
30567000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
30286000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15617000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12581000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1033000
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
934000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3036000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2796000
CY2020Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
165000
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
195000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
67000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
77000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
409000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1261000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
645000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
348000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
214000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2877000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
267000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2610000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
585000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
809000
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
853000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
515000
CY2020Q3 jan Accrued Incentive And Rebate Checks Current
AccruedIncentiveAndRebateChecksCurrent
964000
CY2019Q4 jan Accrued Incentive And Rebate Checks Current
AccruedIncentiveAndRebateChecksCurrent
988000
CY2020Q3 jan Accrued Guarantees Current
AccruedGuaranteesCurrent
767000
CY2019Q4 jan Accrued Guarantees Current
AccruedGuaranteesCurrent
767000
CY2020Q3 jan Accrued Purchase Orders Current
AccruedPurchaseOrdersCurrent
577000
CY2020Q3 jan Accrued Transportation Costs Current
AccruedTransportationCostsCurrent
1265000
CY2020Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
716000
CY2019Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
859000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5727000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3938000
CY2017Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
4132000
CY2017Q2 us-gaap Interest Payable Current
InterestPayableCurrent
500000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.075
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.254
CY2020Q3 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
203000
CY2020Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
3327000
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
280000
CY2020Q1 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
800000
jan Contract With Customer Liability Accrued
ContractWithCustomerLiabilityAccrued
610000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
272000
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
223214
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000000
CY2020Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
71607000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
62000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
100900
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
56500
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
44400
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
4500
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
101900
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.07
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
9.30
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.31
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.85
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
9.45
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.10
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
35000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M2D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M6D
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
76000
jan Share Based Payment Arrangement Nonvested Award Cost Not Yet Recognized Amortized Period
ShareBasedPaymentArrangementNonvestedAwardCostNotYetRecognizedAmortizedPeriod
2021-07
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
33363
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
33363
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.40
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.40
jan Warrant Expiration Date
WarrantExpirationDate
2021-11-30
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
135263
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
134363
CY2020Q3 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
8000
CY2019Q3 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
3000
us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
20000
us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
20000
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1060000
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1076000

Files In Submission

Name View Source Status
0001564590-20-052676-index-headers.html Edgar Link pending
0001564590-20-052676-index.html Edgar Link pending
0001564590-20-052676.txt Edgar Link pending
0001564590-20-052676-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gdfxctmeknvq000001.jpg Edgar Link pending
gdfxctmeknvq000002.jpg Edgar Link pending
jan-10q_20200926.htm Edgar Link pending
jan-20200926.xml Edgar Link completed
jan-20200926.xsd Edgar Link pending
jan-20200926_cal.xml Edgar Link unprocessable
jan-20200926_def.xml Edgar Link unprocessable
jan-20200926_lab.xml Edgar Link unprocessable
jan-20200926_pre.xml Edgar Link unprocessable
jan-ex102_13.htm Edgar Link pending
jan-ex103_223.htm Edgar Link pending
jan-ex311_10.htm Edgar Link pending
jan-ex312_9.htm Edgar Link pending
jan-ex321_8.htm Edgar Link pending
jan-ex322_6.htm Edgar Link pending
jan-ex39_224.htm Edgar Link pending
jan-ex42_14.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending